Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Taiwan - Delayed Quote TWD

YungShin Global Holding Corporation (3705.TW)

Compare
58.80
+0.60
+(1.03%)
At close: April 2 at 1:30:06 PM GMT+8
Loading Chart for 3705.TW
  • Previous Close 58.20
  • Open 57.90
  • Bid 58.70 x --
  • Ask 58.80 x --
  • Day's Range 57.20 - 58.80
  • 52 Week Range 47.30 - 63.30
  • Volume 1,284,563
  • Avg. Volume 741,558
  • Market Cap (intraday) 15.662B
  • Beta (5Y Monthly) 0.08
  • PE Ratio (TTM) 13.39
  • EPS (TTM) 4.39
  • Earnings Date --
  • Forward Dividend & Yield 3.00 (5.10%)
  • Ex-Dividend Date Jun 24, 2025
  • 1y Target Est --

YungShin Global Holding Corporation, through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics. The company is also involved in trade, investment, and other related businesses; import and export trading; and sale of medicine. It has operations in Taiwan, the United States, Mainland China, and Japan. The company was incorporated in 2011 and is headquartered in Taipei City, Taiwan.

www.yungshingroup.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 3705.TW

View More

Performance Overview: 3705.TW

Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .

YTD Return

3705.TW
9.09%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
7.54%

1-Year Return

3705.TW
24.54%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
4.06%

3-Year Return

3705.TW
59.20%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
20.84%

5-Year Return

3705.TW
66.26%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
120.40%

Compare To: 3705.TW

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 3705.TW

View More

Valuation Measures

Annual
As of 4/2/2025
  • Market Cap

    15.66B

  • Enterprise Value

    14.62B

  • Trailing P/E

    13.39

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.95

  • Price/Book (mrq)

    1.97

  • Enterprise Value/Revenue

    1.82

  • Enterprise Value/EBITDA

    7.50

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    13.16%

  • Return on Assets (ttm)

    6.28%

  • Return on Equity (ttm)

    13.10%

  • Revenue (ttm)

    7.82B

  • Net Income Avi to Common (ttm)

    1.03B

  • Diluted EPS (ttm)

    4.39

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.05B

  • Total Debt/Equity (mrq)

    15.06%

  • Levered Free Cash Flow (ttm)

    721.58M

Research Analysis: 3705.TW

View More

Company Insights: 3705.TW

Research Reports: 3705.TW

View More

People Also Watch